Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab
- DOI
- 10.1093/infdis/jiaf159
- Published
- 2025-04-03
- Container
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/infdis/jiaf159,
title = {Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab},
author = {Joseph J Eron and Paul P Cook and Megha L Mehrotra and Hailin Huang and Marina Caskey and Gordon E Crofoot and Linda Gorgos and Laurie A VanderVeen and Yanan Zheng and Sean E Collins and Olayemi O Osiyemi and Cynthia Brinson and Edwin DeJesus},
year = {2025},
journal = {The Journal of Infectious Diseases},
doi = {10.1093/infdis/jiaf159},
url = {https://doi.org/10.1093/infdis/jiaf159}
}RIS
TY - JOUR TI - Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab AU - Joseph J Eron AU - Paul P Cook AU - Megha L Mehrotra AU - Hailin Huang AU - Marina Caskey AU - Gordon E Crofoot AU - Linda Gorgos AU - Laurie A VanderVeen AU - Yanan Zheng AU - Sean E Collins AU - Olayemi O Osiyemi AU - Cynthia Brinson AU - Edwin DeJesus PY - 2025 JO - The Journal of Infectious Diseases DO - 10.1093/infdis/jiaf159 UR - https://doi.org/10.1093/infdis/jiaf159 ER -
APA
Eron, J. J., Cook, P. P., Mehrotra, M. L., Huang, H., Caskey, M., Crofoot, G. E., Gorgos, L., VanderVeen, L. A., Zheng, Y., Collins, S. E., Osiyemi, O. O., Brinson, C., & DeJesus, E. (2025). Lenacapavir Plus 2 Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf159
Source records
- crossref · retrieved 2026-09-27T08:52:50.895Z